Log In
BCIQ
Print this Print this
 

Kayexalate, sodium polystyrene

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSodium polystyrene sulfonate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHyperkalemia
Indication DetailsTreat hyperkalemia
Regulatory Designation
PartnerCovis Pharma S.a.r.l.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/15/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today